GDRX Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
200.4M
+3.3%
194.0M
-0.4%
194.8M
-0.6%
196.0M
-3.5%
203.1M
Cost of Revenue
21.0M
+4.2%
20.2M
+15.4%
17.5M
+30.1%
13.4M
+0.5%
13.3M
Gross Profit
179.4M
+3.2%
173.8M
-2.0%
177.3M
-2.9%
182.6M
-3.7%
189.7M
Operating Expenses
155.8M
-2.5%
159.8M
+3.4%
154.6M
-7.9%
168.0M
+3.1%
162.9M
R&D
26.7M
-11.5%
30.2M
+4.3%
28.9M
-6.7%
31.0M
+3.6%
29.9M
SG&A
106.8M
-1.0%
107.9M
+5.2%
102.6M
-11.2%
115.5M
+2.0%
113.2M
Operating Income
23.6M
+68.7%
14.0M
-38.2%
22.7M
+55.2%
14.6M
-45.5%
26.8M
EBITDA
45.9M
+28.2%
35.8M
-21.9%
45.8M
+27.1%
36.1M
-22.5%
46.5M
Net Income
8.5M
+630.2%
1.2M
-78.5%
5.4M
+384.8%
1.1M
-91.3%
12.8M
EPS (Basic)
$0.03
$0.00
-100.0%
$0.02
$0.00
-100.0%
$0.04
EPS (Diluted)
$0.02
$0.00
-100.0%
$0.02
$0.00
-100.0%
$0.04
Shares (Diluted)
348.1M
+1.9%
341.4M
-0.5%
343.3M
-1.3%
347.8M
-2.6%
357.2M
GoodRx (GDRX) โ€” Financials